Skip to Content Skip to Content

Perelman School of Medicine

Visit the School's Site
Reset All Filters
2720 Results
Researchers at Penn Uncover Mechanism Behind Blood Stem Cells’ Longevity

Researchers at Penn Uncover Mechanism Behind Blood Stem Cells’ Longevity

The blood stem cells that live in bone marrow are at the top of a complex family tree. Such stem cells split and divide down various pathways that ultimately produce red cells, white cells and platelets.

Evan Lerner

Penn Medicine: Paths Not Taken: Notch Signaling Pathway Keeps Immature T Cells on the Right Track

Penn Medicine: Paths Not Taken: Notch Signaling Pathway Keeps Immature T Cells on the Right Track

The lab of Avinash Bhandoola, PhD, professor of Pathology and Laboratory Medicine, has studied the origins of T cells for many years. One protein called Notch, which has well-known roles in the development of multiple tissues, plays an essential role in triggering T-cell development.

Karen Kreeger

Epigenetic Changes May Explain Chronic Kidney Disease, Penn Study Shows

Epigenetic Changes May Explain Chronic Kidney Disease, Penn Study Shows

The research of physician-scientist Katalin Susztak, MD, PhD, associate professor of Medicine in the Renal Electrolyte and Hypertension Division, at the Perelman School of Medicine, University of Pennsylvania, strives to understand the molecular roots an

Karen Kreeger

Penn Medicine: Targets of Anticancer Drugs Have Broader Functions than What Their Name Suggests

Penn Medicine: Targets of Anticancer Drugs Have Broader Functions than What Their Name Suggests

Drugs that inhibit the activity of enzymes called histone deacetylases (HDACs) are being widely developed for treating cancer and other diseases, with two already on the market. Researchers at the Perelman School of Medicine, University of Pennsylvania, show that a major HDAC still functions in mice even when its enzyme activity is abolished, suggesting that the beneficial effects of HDAC inhibitors may not actually be through inhibiting HDAC activity, and thus warranting the reassessment of the molecular targets of this class of drugs.

Karen Kreeger

Penn Medicine: New Study Finds Similar Outcomes for Repair or Replacement of Damaged Heart Valves

Penn Medicine: New Study Finds Similar Outcomes for Repair or Replacement of Damaged Heart Valves

New research presented today at the 2013 Scientific Sessions of the American Heart Association by researchers at the Perelman School of Medicine at the University of Pennsylvania found no difference in outcomes at one-year between two recommended surgical options for treating ischemic mitral regurgitation (IMR) – repair of the leaky valve or its replacem

Jessica Mikulski

Penn Medicine Study Shows Women's Risk of Depression Lowers After Final Menstrual Period

Penn Medicine Study Shows Women's Risk of Depression Lowers After Final Menstrual Period

Risk of depression is lower in menopausal women after their final menstrual period (FMP) but a history of depression increases the risk of depressive symptoms both before and after menopause, according to a new study from researchers at the Perelman School of Medicine at the University of Pennsylvania.

Katie Delach

Sons of Cocaine-Using Fathers May Resist Addiction to Drug, Penn Medicine Study Suggests

Sons of Cocaine-Using Fathers May Resist Addiction to Drug, Penn Medicine Study Suggests

A father’s cocaine use may make his sons less sensitive to the drug and thereby more likely to resist addictive behaviors, suggests new findings from an animal study presented by Penn Medicine researchers at Neuroscience 2013, the annual meeting of the Society for Neuroscience.

Steve Graff

Penn Medicine: Study Shows Moms May Pass Effects of Stress to Offspring Via Vaginal Bacteria and Placenta

Penn Medicine: Study Shows Moms May Pass Effects of Stress to Offspring Via Vaginal Bacteria and Placenta

Pregnant women may transmit the damaging effects of stress to their unborn child by way of the bacteria in their vagina and through the placenta, suggest new findings from two animal studies presented by researchers at the University of Pennsylvania at Neuroscience 2013, the annual meeting of the Society for Neuroscience.

Steve Graff

Penn Medicine: APOL1 Gene Speeds Kidney Disease Progression and Failure in Blacks, Regardless of Diabetes Status

Penn Medicine: APOL1 Gene Speeds Kidney Disease Progression and Failure in Blacks, Regardless of Diabetes Status

A large study co-led by Penn Medicine published this week in the New England Journal of Medicine found that African Americans with the APOL1 gene variant experience faster progression of chronic kidney disease (CKD) and have a significantly increased risk of kidney failure, regardless of their diabetes status.

Steve Graff